WMIF MAIN SITE
2026 Event SiteMonday, June 12, 2023
9:45 AM - 10:30 AM
Watch Panel HereThis panel will take a focused look at the potential implications of the Inflation Reduction Act (IRA) of 2022 on biopharmaceutical innovation. While the full impact of the IRA is not yet clear, drug developers, patient advocates and other stakeholders are watching for the potential impact on small molecule drug development, on overall development of cancer therapies, on patient care for major chronic diseases, among other concerns.
We use cookies to improve your browsing experience, analyze website traffic, and personalize content. By clicking “Accept All” you consent to our use of cookies. You can manage your preferences at any time. See our Privacy Policy.
We use cookies to run this site and, with your permission, to analyze traffic and personalize content. Choose which cookies to allow. See our Privacy Policy.
Required for the website to work. Always active.
Lets us measure website traffic and personalize content through Google Analytics. Nothing loads until you allow it.